Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandro Vivona

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Developmental Cell|December 4, 2012
ALIX is a Lys63-specific polyubiquitin binding protein that functions in retrovirus buddingDara P Dowlatshahi, Virginie Sandrin, Sandro Vivona, et al.
Antibodies (Basel, Switzerland)|September 22, 2025
Structure-Guided Stapling of Dimeric Conformations and Linker Engineering Enhance Thermostability and Fine-Tune Activity of Bispecific VHH Cytokine AgonistsRaphael Trenker, Deepti Rokkam, Andrew Morin, et al.
Vaccine|September 28, 2011
Improving reverse vaccinology with a machine learning approachBrett N Bowman, Paul R McAdam, Sandro Vivona, et al.
Journal of the American Chemical Society|August 18, 2020
Reduction Triggered <i>In Situ</i> Polymerization in Living MiceLina Cui, Sandro Vivona, Bryan Ronain Smith, et al.
Nature|February 18, 2015
ATG14 promotes membrane tethering and fusion of autophagosomes to endolysosomesJiajie Diao, Rong Liu, Yueguang Rong, et al.
Science Translational Medicine|December 22, 2021
An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CAR T cells and clearance of bulky lymphomaPaul-Joseph Aspuria, Sandro Vivona, Michele Bauer, et al.
The Journal of Biological Chemistry|February 27, 2015
Munc18a does not alter fusion rates mediated by neuronal SNAREs, synaptotagmin, and complexinYunxiang Zhang, Jiajie Diao, Karen N Colbert, et al.
Cell Reports|December 20, 2025
An IL-12 partial agonist sustains intratumoral lymphocyte activation and detoxifies systemic IL-12 therapyIevgen Koliesnik, Michael Totagrande, Bhargavi Jayaraman, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Developmental Cell|December 4, 2012
ALIX is a Lys63-specific polyubiquitin binding protein that functions in retrovirus buddingDara P Dowlatshahi, Virginie Sandrin, Sandro Vivona, et al.
Antibodies (Basel, Switzerland)|September 22, 2025
Structure-Guided Stapling of Dimeric Conformations and Linker Engineering Enhance Thermostability and Fine-Tune Activity of Bispecific VHH Cytokine AgonistsRaphael Trenker, Deepti Rokkam, Andrew Morin, et al.
Vaccine|September 28, 2011
Improving reverse vaccinology with a machine learning approachBrett N Bowman, Paul R McAdam, Sandro Vivona, et al.
Journal of the American Chemical Society|August 18, 2020
Reduction Triggered <i>In Situ</i> Polymerization in Living MiceLina Cui, Sandro Vivona, Bryan Ronain Smith, et al.
Nature|February 18, 2015
ATG14 promotes membrane tethering and fusion of autophagosomes to endolysosomesJiajie Diao, Rong Liu, Yueguang Rong, et al.
Science Translational Medicine|December 22, 2021
An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CAR T cells and clearance of bulky lymphomaPaul-Joseph Aspuria, Sandro Vivona, Michele Bauer, et al.
The Journal of Biological Chemistry|February 27, 2015
Munc18a does not alter fusion rates mediated by neuronal SNAREs, synaptotagmin, and complexinYunxiang Zhang, Jiajie Diao, Karen N Colbert, et al.
Cell Reports|December 20, 2025
An IL-12 partial agonist sustains intratumoral lymphocyte activation and detoxifies systemic IL-12 therapyIevgen Koliesnik, Michael Totagrande, Bhargavi Jayaraman, et al.
Pageof 2